Vaibhav Suryavanshi’s Breakthrough on the Senior Stage

Fourteen-year-old Vaibhav Suryavanshi announced himself on India’s senior domestic circuit with a stunning performance in the Vijay Hazare Trophy, producing one of the most remarkable innings in List A cricket history. Playing at the JSCA Oval Ground in Ranchi, the teenage batter showcased fearless stroke play and exceptional maturity, highlighting the depth of India’s emerging batting talent.

China–India Trade Dispute at the WTO

China has initiated a formal trade dispute against India at the World Trade Organization (WTO), escalating economic tensions between the two Asian economies. Beijing has sought consultations with New Delhi, alleging that India’s policy measures supporting the solar and information technology sectors violate global trade rules and unfairly discriminate against Chinese products.

LVM3-M6 Mission Highlights India’s Growing Role in Global Space Commerce

India’s space sector is set to achieve another major commercial milestone with the launch of the BlueBird Block-2 communication satellite for a United States-based company on December 24. The mission underlines India’s emergence as a trusted global launch service provider and showcases the expanding commercial use of its heavy-lift launch vehicle, LVM3.

India offers major reconstruction assistance to Sri Lanka after Cyclone Ditwah

India has proposed a $450 million assistance package to support Sri Lanka’s reconstruction efforts following the widespread devastation caused by Cyclone Ditwah. The announcement was made during the visit of India’s External Affairs Minister S. Jaishankar to Colombo, underscoring New Delhi’s role as both a first responder and a long-term development partner in the Indian Ocean region.

FDA clears first prescription oral iron medicine for children

In a significant advance for paediatric healthcare, the United States Food and Drug Administration (FDA) has approved the first prescription oral medicine to treat iron deficiency in children aged 10 years and above. The decision expands therapeutic options beyond dietary supplements and injectable treatments, addressing a widespread but often underdiagnosed nutritional disorder among school-age children and adolescents.